Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Dettori

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Aesthetic Surgery Journal|May 26, 2025
Postsurgical Pyoderma Gangrenosum in Breast Surgery: An Updated Systematic Review, Takeaways, and the 6 CommandmentsGiorgio Caddia, Delphine Voulliaume, Laura Dettori, et al.
Sports (Basel, Switzerland)|September 27, 2024
Association of VDR Polymorphisms with Muscle Mass Development in Elite Young Soccer Players: A Pilot StudyLaura Flore, Renato Robledo, Laura Dettori, et al.
Journal of Medicinal Chemistry|April 5, 2025
Deuteration Strategy-Inspired Design of Novel Diarylpyrimidine Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Improved Efficacy, Selectivity, and DruggabilityKun Zhang, Tianhao Xing, Li Ding, et al.
European Journal of Medicinal Chemistry|January 15, 2025
Structure-based discovery of novel diarylpyrimidines as potent and selective Non-Nucleoside reverse transcriptase inhibitors: From CH(CN)-Biphenyl-Diarylpyrimidines to CNNH<sub>2</sub>-Biphenyl-DiarylpyrimidinesXiao-Mei Chen, Christophe Pannecouque, Erik De Clercq, et al.
Molecules (Basel, Switzerland)|May 14, 2025
Design, Synthesis and Biological Evaluation of 3-Hydrazonoindolin-2-one Derivatives as Novel HIV-1 RNase H InhibitorsYiying Zhang, Rao Wang, Yueyue Bu, et al.
Journal of Medicinal Chemistry|January 9, 2026
Cyclization-Inspired Structural Optimization: Designing Potent Non-nucleoside Reverse Transcriptase Inhibitors with Enhanced Safety and SelectivityYin-Xiang Zhang, Christophe Pannecouque, Erik De Clercq, et al.
Acta Pharmaceutica Sinica. B|July 15, 2026
Scaffold hopping yields novel furo[3,2-<i>d</i>]pyrimidine NNRTIs with optimized antiviral potency, enhanced selectivity, and reduced hERG liabilityYin-Xiang Zhang, Christophe Pannecouque, Erik De Clercq, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Aesthetic Surgery Journal|May 26, 2025
Postsurgical Pyoderma Gangrenosum in Breast Surgery: An Updated Systematic Review, Takeaways, and the 6 CommandmentsGiorgio Caddia, Delphine Voulliaume, Laura Dettori, et al.
Sports (Basel, Switzerland)|September 27, 2024
Association of VDR Polymorphisms with Muscle Mass Development in Elite Young Soccer Players: A Pilot StudyLaura Flore, Renato Robledo, Laura Dettori, et al.
Journal of Medicinal Chemistry|April 5, 2025
Deuteration Strategy-Inspired Design of Novel Diarylpyrimidine Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Improved Efficacy, Selectivity, and DruggabilityKun Zhang, Tianhao Xing, Li Ding, et al.
European Journal of Medicinal Chemistry|January 15, 2025
Structure-based discovery of novel diarylpyrimidines as potent and selective Non-Nucleoside reverse transcriptase inhibitors: From CH(CN)-Biphenyl-Diarylpyrimidines to CNNH<sub>2</sub>-Biphenyl-DiarylpyrimidinesXiao-Mei Chen, Christophe Pannecouque, Erik De Clercq, et al.
Molecules (Basel, Switzerland)|May 14, 2025
Design, Synthesis and Biological Evaluation of 3-Hydrazonoindolin-2-one Derivatives as Novel HIV-1 RNase H InhibitorsYiying Zhang, Rao Wang, Yueyue Bu, et al.
Journal of Medicinal Chemistry|January 9, 2026
Cyclization-Inspired Structural Optimization: Designing Potent Non-nucleoside Reverse Transcriptase Inhibitors with Enhanced Safety and SelectivityYin-Xiang Zhang, Christophe Pannecouque, Erik De Clercq, et al.
Acta Pharmaceutica Sinica. B|July 15, 2026
Scaffold hopping yields novel furo[3,2-<i>d</i>]pyrimidine NNRTIs with optimized antiviral potency, enhanced selectivity, and reduced hERG liabilityYin-Xiang Zhang, Christophe Pannecouque, Erik De Clercq, et al.
Pageof 1